References in periodicals archive ?
Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period.
Quality of life and metabolic control in patients with diabetes mellitus type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections.
Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus.
Guidance on the use of continuous subcutaneous insulin infusion for diabetes.
Continuous subcutaneous insulin infusion therapy for children and adolescents: An option for routine diabetes care.
Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
Pubertal patients with type 1 diabetes who transition from multiple daily injections to continuous subcutaneous insulin infusion should decrease their total daily insulin dosage, but the dosage for prepubertal patients can remain unchanged.
In a retrospective chart review of 65 children who switched from multiple daily injections to continuous subcutaneous insulin infusion, before starting the pump, the mean total insulin dose was 1.
to assist in the development of an Ambulatory Diabetes Pump to be used for continuous subcutaneous insulin infusion.
In two studies, 20 patients with type 1 diabetes were first randomized to receive subcutaneous injections of either glargine or NPH insulin, then again to receive either subcutaneous Ultralente insulin or continuous subcutaneous insulin infusion via an insulin pump, said Dr.
Design and development of a product section, as well as an educational page about Continuous Subcutaneous Insulin Infusion (CSII) therapy, an intensive insulin therapy for diabetes that is often called insulin pump therapy;

Full browser ?